Literature DB >> 19781659

Survival of secondary lethal systemic Francisella LVS challenge depends largely on interferon gamma.

Karen L Elkins1, Susan M Colombini, Anda I Meierovics, May C Chu, Alicia Y Chou, Siobhán C Cowley.   

Abstract

Although survival of primary infection with the live vaccine strain (LVS) of Francisella tularensis depends on interferon gamma (IFN-gamma), the relative importance of IFN-gamma to secondary protective immunity in vivo has not been clearly established. Here we examine the role of IFN-gamma in T cell priming and expression of vaccine-induced protection against lethal intraperitoneal challenge of mice. Large amounts of IFN-gamma were detected between days 3 and 7 in the sera of LVS-immunized mice, while relatively small amounts were found transiently after secondary LVS challenge. Consistent with the production of this cytokine, mice lacking IFN-gamma (gamma interferon knockout, GKO, mice) could not be successfully vaccinated with LVS or an attenuated mglA mutant of F. novicida to withstand secondary Francisella LVS challenge. Further, splenocytes from such primed mice did not adoptively transfer protection to naive GKO recipient mice in vivo, nor control the intramacrophage growth of LVS in vitro. Finally, LVS-immune WT mice depleted of IFN-gamma prior to intraperitoneal challenge survived only the lowest doses of challenge. Thus successful priming of protective LVS-immune T cells, as well as complete expression of protection against Francisella during secondary challenge, depends heavily on IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781659     DOI: 10.1016/j.micinf.2009.09.012

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  15 in total

1.  IL-12Rβ2 is critical for survival of primary Francisella tularensis LVS infection.

Authors:  Amanda A Melillo; Oded Foreman; Karen L Elkins
Journal:  J Leukoc Biol       Date:  2013-02-25       Impact factor: 4.962

2.  Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.

Authors:  Katharina Richard; Barbara J Mann; Lenea Stocker; Eileen M Barry; Aiping Qin; Leah E Cole; Matthew T Hurley; Robert K Ernst; Suzanne M Michalek; Daniel C Stein; Philip Deshong; Stefanie N Vogel
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

3.  Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs.

Authors:  Rebecca V Anderson; Deborah D Crane; Catharine M Bosio
Journal:  Vaccine       Date:  2010-08-03       Impact factor: 3.641

4.  Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection.

Authors:  Sherry L Kurtz; Oded Foreman; Catharine M Bosio; Miriam R Anver; Karen L Elkins
Journal:  Infect Immun       Date:  2012-12-10       Impact factor: 3.441

5.  Infection of mice with Francisella as an immunological model.

Authors:  J Wayne Conlan; Wangxue Chen; Catharine M Bosio; Siobhán C Cowley; Karen L Elkins
Journal:  Curr Protoc Immunol       Date:  2011-04

6.  A MyD88-dependent IFNγR-CCR2 signaling circuit is required for mobilization of monocytes and host defense against systemic bacterial challenge.

Authors:  Eric M Pietras; Lloyd S Miller; Carl T Johnson; Ryan M O'Connell; Paul W Dempsey; Genhong Cheng
Journal:  Cell Res       Date:  2011-04-05       Impact factor: 25.617

7.  IFN-γ, but not IL-17A, is required for survival during secondary pulmonary Francisella tularensis Live Vaccine Stain infection.

Authors:  Lydia M Roberts; John S Davies; Gregory D Sempowski; Jeffrey A Frelinger
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641

Review 8.  Differential Immune Response Following Intranasal and Intradermal Infection with Francisella tularensis: Implications for Vaccine Development.

Authors:  McKayla J Nicol; David R Williamson; David E Place; Girish S Kirimanjeswara
Journal:  Microorganisms       Date:  2021-04-30

9.  Immunity to Francisella.

Authors:  Siobhán C Cowley; Karen L Elkins
Journal:  Front Microbiol       Date:  2011-02-16       Impact factor: 5.640

10.  A Francisella tularensis live vaccine strain that improves stimulation of antigen-presenting cells does not enhance vaccine efficacy.

Authors:  Deanna M Schmitt; Dawn M O'Dee; Joseph Horzempa; Paul E Carlson; Brian C Russo; Jacqueline M Bales; Matthew J Brown; Gerard J Nau
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.